comparemela.com

Latest Breaking News On - Australian headquartered - Page 1 : comparemela.com

Lantheus Selects GenesisCare to Administer First Commercial Dose of PYLARIFY®, the First and Only FDA-Approved PSMA PET Imaging Agent for Men with Prostate Cancer

Cancer Patients in Asheville Benefit from Major Boost to GenesisCare Surgical Oncology Program

Cancer Patients in Asheville Benefit from Major Boost to GenesisCare Surgical Oncology Program Five highly regarded surgical Oncologists join Comprehensive Cancer Treatment Center Utilizing Artificial Intelligence and Robotics News provided by Share this article ASHEVILLE, N.C., April 29, 2021 /PRNewswire/  GenesisCare one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom today announced the addition of five well-respected surgeons to the Asheville team of GenesisCare USA of North Carolina, PA. GenesisCare Surgical Specialists will be working to put into practice more than 20 life-saving surgical procedures providing comprehensive cancer care across medical and radiation oncology. The collection of comprehensive procedures and surgeons allows the facility to offer treatments for breast, colon, pancreatic, thyroid, skin, and other metastatic cancers.  

GenesisCare Brings Western North Carolina Cancer Patients Elekta Versa HD™ Technology

GenesisCare Brings Western North Carolina Cancer Patients Elekta Versa HD™ Technology New Linear Radiotherapy Shortens Brain, Lung, and Metastases Treatment Time With Better Results, While Reducing Damage to Healthy Tissue News provided by Share this article ASHEVILLE, N.C., Feb. 18, 2021 /PRNewswire/ GenesisCare  one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom today announced the addition of the new Elekta Versa HD™ at its Asheville location. This innovative technology is available to oncology patients with brain, lung, and metastases cancer throughout Western North Carolina and nearby areas. With shorter treatment times, this hypofractionated radiation therapy provides the highest level of dose delivery accuracy while pushing the boundaries of stereotactic capabilities that can be delivered in a standard therapy slot of 15 minutes or less, which was not previously possible.

GenesisCare Brings Florida Cancer Patients First-of-its-Kind Ethos™ Adaptive Intelligence™ Technology

Share this article Share this article NAPLES, Fla., Feb. 4, 2021 /PRNewswire/  GenesisCare one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom today announced the addition of a game-changing adaptive therapy, the Varian Ethos™. Designed to create customized cancer-fighting treatments, this technology targets tumors and accounts for body changes and shrinking cancers. Personalized patient care is one of GenesisCare s commitments to the community and this treatment helps put the patient at the center of care. This technology allows oncologists to quickly adapt treatment plans based on their ability to view daily changes in the patient s anatomy. What used to take two-three days now takes 15-minutes.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.